Education and public awareness are crucial for patients navigating BCG-unresponsive non-muscle invasive bladder cancer treatment options.

Dr. Anjana Pillai explains, in an interview with CURE, that treatment for liver cancer depends heavily on stage, liver ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

Compartmentalizing the diagnosis allowed her to continue working, using her professional life as a refuge during treatment.

It wasn’t that I never expected a breast cancer diagnosis, it was that I had never even considered a breast cancer diagnosis.

Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Cancer Institute in Boston, ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

On Sept. 5, 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo (gemcitabine intravesical system) for adults ...

Regular exercise and a fiber-rich diet are vital for reducing cancer risk in Lynch syndrome patients. Aspirin, particularly ...

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

He currently serves as the director of Sarcoma Pathways and is a physician at Dana-Farber Cancer Institute, in Boston, Massachusetts, where is also an instructor in medicine and an affiliated faculty ...

Chester Freeman, living with chronic lymphocytic leukemia, shares the Japanese philosophy of wabi-sabi as a guide for patients with cancer. He defines the tradition as "accepting the imperfections in ...